Precision Medicine has been gaining ground as more and more providers prescribe genetics tests and more payers decide to cover it. In this panel, experts in the field will provide a broad overview of where we are and where we need to go to make the promise and potential of precision medicine a reality.
Moderator: Jonathan Hirsch, Syapse Founder
Speakers:
- Daniel Knecht, MD, Vice President, Transformation Clinical Product, CVS Health
- David Spetzler, PhD, President and Chief Scientific Officer, Caris Life Sciences
- Nephi Walton, MD, Associate Medical Director of Precision Genomics, Intermountain Healthcare
